BCL2 and breast cancer: Decreased Bax/Bcl-2 ratio and caspase activity are the main mechanisms that cause the malignant glioblastoma cell line U87MG to be resistant to temozolomide (TMZ) [18] and the breast cancer cell line MCF-7 to be resistant to paclitaxel [19].